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Abstract
Objective: Few methodological studies address the prioritization of clinical topics for the development of Clinical
Practice Guidelines (CPGs). The aim of this study was to validate a methodology for Priority Determination of
Topics (PDT) of CPGs.
Methods and results: Firstly, we developed an instrument for PDT with 41 criteria that were grouped under 10
domains, based on a comprehensive systematic search. Secondly, we performed a survey of stakeholders involved
in CPGs development, and end users of guidelines, using the instrument. Thirdly, a pilot testing of the PDT
procedure was performed in order to choose 10 guideline topics among 34 proposed projects; using a multi-
criteria analysis approach, we validated a mechanism that followed five stages: determination of the composition
of groups, item/domain scoring, weights determination, quality of the information used to support judgments, and
finally, topic selection. Participants first scored the importance of each domain, after which four different weighting
procedures were calculated (including the survey results). The process of weighting was determined by correlating
the data between them. We also reported the quality of evidence used for PDT. Finally, we provided a qualitative
analysis of the process. The main domains used to support judgement, having higher quality scores and
weightings, were feasibility, disease burden, implementation and information needs. Other important domains such
as user preferences, adverse events, potential for health promotion, social effects, and economic impact had lower
relevance for clinicians. Criteria for prioritization were mainly judged through professional experience, while good
quality information was only used in 15% of cases.
Conclusion: The main advantages of the proposed methodology are supported by the use of a systematic
approach to identify, score and weight guideline topics selection, limiting or exposing the influence of personal
biases. However, the methodology was complex and included a number of quantitative and qualitative approaches
reflecting the difficulties of the prioritization process.
Introduction
The need to set priorities for developing Clinical Prac-
tice Guidelines (CPGs) has been recognized by several
CPG developers, in part due to the rapid development
of medical technology and finite resources of organiza-
tions [1,2]. Although choosing which topic to address in
CPGs (prioritization) is a process that is not always fol-
lowed by standardized processes, explicit and/or implicit
choices about how to allocate funds and staff time to
particular projects must be made by organizations [1-3].
Prioritization to Determine Topics (PDT) for CPGs is
frequently influenced by the availability of human and
financial resources. PDT also varies according to specific
needs of sponsors, such as health care organizations and
the different hierarchical levels within the health
research system [3,4]. A methodology that uses explicit
criteria and a systematic approach for PDT may facili-
tate the implementation of an open, verifiable and
reproducible PDT [5]. Although qualitative and quanti-
tative methods have been used in PDT, there are few
published studies addressing the group selection and
methodology that has been followed when picking clini-
cal topics for the development of CPGs [5-8]. * Correspondence: mmreveiz@hotmail.com
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for CPGs in order to evaluate the topics identified with
this methodology and see if they were, in fact, consid-
ered high priority.
Methods
The primary aim of this study was to develop and vali-
date an explicit methodology for PDT of CPGs within
the setting of a developing country. We used a number
of different approaches to develop and assess the PDT
process: instrument development; an external survey; a
pilot testing of the PDT procedure and; a qualitative
evaluation. The PDT procedure integrated quantitative
and qualitative data from different sources. A summary
of the stages of the PDT procedure as well as the meth-
odological approaches used for validating the process
are shows in Figure 1a and 1b respectively.
Instrument development
We developed a formal instrument for prioritizing
guideline topics with the following characteristics:
domain/criteria importance; quality of the supporting
evidence for scoring each domain; availability of
supporting bibliography; additional domains or criteria
not listed in the tool.
Identification of domain/criteria for PDT
To identify criteria for PDT and summarize knowledge,
methods and strategies used for PDT in CPGs develop-
ment, we conducted a systematic search in the following
databases: MEDLINE (PUBMED 1966 to July 2008),
The Cochrane Library (Issue 2, 2008) and LILACS
(1982 to July 2008). Unfortunately, we did not have
access to CINAHL, which frequently contains useful
studies. The search strategy was structured and adapted
according to each electronic database (Appendix 1).
Besides, we reviewed the websites of several recognized
governmental and nongovernmental organizations that
produce CPGs, including the National Institute for Clin-
ical Excellence http://www.nice.org.uk, the Scottish
Intercollegiate Guidelines Network http://www.sign.ac.
uk, the World Health Organization [WHO; http://www.
who.int], the New Zealand Guidelines Group http://
www.nzgg.org.nz/, The Canadian Medical Association
InfoBase, Guidelines Advisory Committee http://www.
gacguidelines.ca/ National Guideline Clearinghouse
http://www.guideline.gov/resources/guideline_resources.
Figure 1 Stages of the PDT procedure (left side) and methodological approaches used for validating the process (right side).
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search included observational, descriptive, comparative,
interventional studies and reports published in CPG
clearinghouses. A number of reports were identified and
analyzed [5-7,9-17]; however only one methodological
paper on CPG prioritization was identified [5]. Forty-
one items were determined and categorized into 10
domains, established a priori (Table 1) related with
CPGs and other research prioritization papers [5-7,9-17]
and websites of CPG producers.
Scoring each domain
According to its perceived importance, each of the ten
domains was scored independently by evaluators accord-
ing to a preference scale from 0 to 100.
Table 1 Criteria for setting priorities according to their assessed importance by participants and external
stakeholders.
Domain Items Mean
participants’
weighted
score (SD)
Disease Burden - Disease/Condition incidence or prevalence
- High risk impact of disease/condition in the health system
- High frequency of risk factors associated with the disease/condition
- High frequency of avoidable risk factors associated with the disease/condition
80,8 (18,2)
Information needs in the Health
Sector
- Information needs within the Institution/Organization
- Current controversy about topic importance
- High importance of new methods and technology assessment
- Fast diffusion of non-assessed technologies, availability of resources and sufficient time for
technologies implementation
- Country health priorities in agreement with CPG’s needs
- High impact on national health system
74,7 (18,1)
Feasibility on development and
implementation
- Feasibility on recommendations development which will improve health outcomes and cost
- Is the proposal politically feasible?
- Does it belong to priority health areas according to government policies?
- Feasibility in implementation; will not require an excessive amount of resources and will not
present important barriers to implement changes
- Will reduce inequities when implemented
- Will require education to training professionals
- Does the proposed topic include the participation of multiple departments, institutions,
organizations, etc?
72,7 (17,1)
Effectiveness - Availability of effective methods shown by methodologically adequate studies.
- Certainty about effectiveness of assessed interventions and technologies
- Potential impact of CPG
71,2 (20,7)
Economic impact on the health
system
- Economic effects on health system (cost of an individual patient is high during diagnosis or
therapeutic process)
- Disease/Condition associated with iatrogenic interventions that are significantly high in cost.
69,8 (24,0)
Clinical Practice Variation - Current evidence is insufficient for disease control in the population
- Lack of high quality CPGs
- Availability of high volume of evidence regarding the CPG topic
- Evidence of inappropriate use of available technologies used in the treatment of condition
(iatrogenic)
- Conditions/diseases where effective treatments could reduce mortality or morbidity
- Evidence of disagreements between current treatment and literature recommendations.
68,0 (22,1)
Other social effects/Equity - Absenteeism from work or school, inability to work, inequities in access to health services
- Will the service be available to anyone who requires it?
- Will this CPG have a positive or negative impact on minorities’ access to health services?
- Will the CPG increase health service access to those affected by the condition?
67,2 (25,7)
User Preferences - High patient demand or interest
- Concerns about patients’ quality of life
- Feasibility of patient empowerment
- High acceptability of the topic between the general public and professionals affected by the use
of the CPG.
64,9 (22,3)
Adverse events - Possibility of adverse events
- Possibility of serious adverse events
- Disease/condition associated with high incidence of adverse events or sequels
57,1 (28,0)
Health Promotion and Disease
Prevention
- Feasibility of prevention between patients with risk factors
- Are there specific activities of health promotion, disease prevention, early diagnosis or
treatment? Have all of them shown a reduction in disease burden?
56,4 (32,3)
* The maximum score was 100 and the minimum was 0
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The quality of the information used to support each
judgment for every prioritized topic (for each of the 41
items in the instrument) was categorized as follows:
good quality information; moderate quality information;
bad quality information; professional experience only;
no information or not applicable.
Face validity
Face validity of the instrument was evaluated by four
epidemiologists, a public health physician, a psycholo-
gist, and a health administrator. Evaluators were in
agreement that the instrument appeared sound and rele-
vant with a logical tie between the purpose and the cri-
teria, without areas of omission. Questions and
instructions were considered clear, unambiguous, logical,
grammatically correct and free of excess wording.
Choice options were also judged to be appropriate for
the instrument and clearly defined. An English version
of the instrument is available as an additional file [see
Additional file 1].
External questionnaire
Because the judgment about the importance of a
domain may vary according to several factors, such as
the proposed topic or the background of the decision
makers, we surveyed a number of stakeholders involved
in CPG development, in addition to end users of guide-
lines. The objective of the survey was to collect data in
order to compare different rating procedures for the
prioritization methodology (see below).
The convenience surveyed sample consisted of 90 peo-
ple, comprising external stakeholders involved in CPG,
and end users of guidelines (patients, health care provi-
ders including clinical staff, government officials, repre-
sentatives from the pharmaceutical industry and private
health care managers and academic researchers) that
were identified from different sources (research institu-
tion lists, guideline developers and stakeholders from
Colombia found in Google Scholar, colleagues etc.) and
who had an active electronic address. As electronic sur-
veys usually have lower rate response [18], we expected
that at least 50% of surveyed reply.
Each participant was sent a survey via an email con-
taining the instrument, as well as instructions for rat-
ing each domain according to its relevance for PDT in
C P G s .U pt of o u rr e m i n d e r sw a ss e n t .T h em a i no u t -
come was the rating score for each dominium (range
0 to 100). No particular topic for CPG development
w a su s e da tt h i ss t a g e .W ea l s oa s k e dp a r t i c i p a n t s
about additional domains or criteria not listed in the
tool, as well as additional commentaries on the instru-
ment. We received 60 responses representing all dif-
ferent types of participants. There was no significant
difference in the proportion of the different types of
respondents (data not shown). No substantial modifi-
cations to the instrument were suggested. Results on
weights for each domain were incorporated in the rat-
ing procedures (see the “weighting the domains“
section).
Pilot testing of the PDT procedure
1. Design
Taking into account the fact that ten CPG topics should
be selected from the process, the final objective of the
study was to develop and validate an explicit methodol-
ogy for PDT of CPGs. We also tested different strategies
for weighting the domains. The PDT model adopted in
this study is based on a multi-criteria analysis approach
which contains five stages [6,7]:
1.1 Composition of the guideline development team
The composition of the CPG development panel may
have an impact on the content of the guideline recom-
mendations. Empirical evidence shows that panels with
more than 12 members may have better judgment
[8-12]. Bearing in mind that there are technical and
administrative issues that are important to PDT, we
worked on two distinct groups: thematic and adminis-
trative. The thematic group included three experts on
the field and one methodological consultant. Experts
from the thematic group included 30 representatives
from nine departments of the Medical School and one
from the Nursing School of the National University of
Colombia (cardiology, gynecology, anesthesia, surgery,
pediatrics, radiology (2 teams), nursing, endocrinology
and neurology departments). The administrative teams
included an expert in psychology, two members from
the hospital board and a project manager. Finally, all 38
participants were involved in the methodology for PDT
of 10 different CPGs.
Following a workshop which had explained the meth-
odology for PDT to the team members, the thematic
team suggested three to five clinical topics that could
potentially be selected for developing a CPG. Subse-
quently, participants used the instrument to score the
importance of domains for each proposed topic. A web-
based tool was developed to allow participants to com-
municate and track the guideline development process.
The selection of topics was completed three weeks later
in a second meeting.
1.2 Scoring domains As mentioned before, 41 items
were determined and categorized into 10 domains
(Table 1). To allow participants to use the predefined
criteria in categorizing information into the various
domains, we developed a guiding document that con-
tained a list of domains in alphabetical order (in Span-
ish). Participants were asked to score each proposed
topic for its importance, rate the quality of the support-
ing evidence, the availability of supporting bibliography,
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listed in the tool (see Annex1).
1.3 Weighting the domains We followed the methodol-
ogy proposed by Oortwijn et al. [5] by weighting each
domain and then using standardized scores according to
this equation:
S Min Max Min      */ 100
S = score of each domain
Min = Lowest score allocated by participants
Max = Highest score allocated by participants
We first applied a “non-weighted procedure” in which
total scores (TS) were the sum of each domain (without
categories adjustment):
T S=A+B+C+D+E+F+G+H+I+J
Subsequently, domains were grouped by disease, social
and economic considerations (Table 2).
A second weighting strategy followed the “equal
weights procedure” adjustment:
TS = (A + C + D + H) + ((E + F)*2) + (B + G + I + J)
The third weighting strategy was a “different weights
procedure” in which each type was adjusted in accor-
dance with the final Oortwijn’s weighting strategy [5]:
TS = (A + C + D + H) + ((E + F)*0.5) + (B + G + I + J)
We developed the fourth weighting strategy to adjust
the type II and III criteria weights according to the
“reported preferences” of CPG users’ external survey:
T S=( A+C+D+H )+( ( B+G+I+J )* 0 . 5 )+
((E + F)*0.25)
We sorted scores in ascending order and calculated
their distribution by percentiles to generate strata by
topic relevance, grading topics in the following cate-
gories: low relevance for those in the first quartile; inter-
mediate relevance for those in the two interquartile
ranges; and high relevance for the upper quartile. We
compared the relevance qualification obtained for the
ten selected topics in each one of the weighting
methods.
1.4 Classification of evidence used for PDT Partici-
pants rated the quality of the information used to sup-
port their judgments for each of the 41 items on the
form, as previously described. Professionals with metho-
dological and scientific literature search expertise (epide-
miologists and information specialists) assisted the
teams when requested and provided relevant references
as needed.
1.5 Selection of topics Depending on which teams were
weighing the topics, rankings were categorized by (1)
thematic team, (2) methodological team, or (3) adminis-
trative team. Rankings listed topics as having low, inter-
mediate or high relevance and then a final selection was
made during a consensus meeting in which the pre-
defined tools were used.
2. Data collection
After being informed of the purpose and nature of the
procedure, requirements and responsibilities of partici-
pants, an Excel sheet file was sent to all participants by
email. Trained evaluators assisted as needed with com-
pletion of the information. Data was collected in an
Excel file and analyzed using Stata 8.0.
3. Statistical analysis of data
To evaluate different strategies for weighting the
domains, we tested the null two-sided hypothesis with
a 90% power and 5% significance for a correlation
effect of 0.5. Therefore, we needed a sample size of 31
participants [Ho: r0 = 0; 90% power; 5% level (two-
sided)] using the methods described by Kraemer [19]
for nonparametric tests. We estimated means, medians
and ranks of weightings and quality scores by topic
(items). We used the Kruskal-Wallis test to examine
differences between the ranks of the median
Table 2 Groups of domains according to their potential effects on health, cost, feasibility and health policy.
Type I Disease Burden
Criteria with potential effects on health Effectiveness
Adverse Events
Health Promotion
Type II Feasibility on development and implementation
Criteria with potential effects on cost and feasibility Economic impact on health system
Type III Information needs within the health sector
Additional aspects relevant for health policy Other social effects/equity
User preferences
Clinical practice variation
Classification of domain for the weighting strategies: A: Disease Burden; B: Information needs in the Health Sector; C: Effectiveness; D: Adverse events; E:
Feasibility on development and implementation; F: Economic impact on the health system; G: Other social effects/Equity; H: Health Promotion and Disease
Prevention; I: User Preferences; J: Clinical Practice Variation
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topics. We considered P < 0.05 (two-sided) to be sig-
nificant for each test. We hypothesized that particular
domains are used for decision-making. Principal
components analysis of the partial correlation matrix
(Varimax rotation) was used to identify underlying
factors.
Qualitative evaluation
1. Participants and materials
36 of the 38 participants in the prioritization of topics
received by email an open-ended questionnaire inquir-
ing about their experience with the prioritization pro-
cess. Up to two reminders were sent. Data from
respondents were collected by a psychologist for
analysis.
2. Procedures
The questionnaire was centered on the following areas:
- Advantages, limitations and barriers of using the
instrument
- Facilitators, limitations and barriers of the PDT
procedure
- Power relation within groups
- Others
This was complemented with direct observation meth-
ods to identify their reactions to the process during the
two meetings. The sessions were facilitated by a guide-
line methodologist and co-moderated by the
psychologist.
3. Data analysis
Methods used for data analysis included speech analysis
(written data) and triangulation of arguments (verbal
data); both were led by a psychologist (PM). Three steps
for analysis were followed:
Step 1. A content analysis of the text of the survey
was performed as follows [20] 1. Responses were thor-
oughly read in extensor several times, aiming for a glo-
bal understanding of the content.
2. Data was categorized under different themes.
3. Main themes were condensed. Inferences were
drawn collectively by careful reading of the text under
each theme.
4. Deviant cases of participants’ statements were
identified.
Step 2. Analysis of key features during meetings The
g r o u ps e s s i o n sf o l l o w e dt h efollowing pattern: i) wel-
come and self-introduction, ii) explanation of the instru-
ment and PDT procedure, iii) general discussion proper,
iv) organization of the ten different groups representing
nine departments of the Medical School and one from
the Nursing School in order to generate a discussion of
the particular topics, v) general discussion, allowing par-
ticipants to speak if they had anything further to say,
and vi) appreciation for participation.
Each group also had a moderator (from the methodo-
logical team) and an observer (psychologist). As only
one experienced psychologist was available, working
groups were evaluated at different times during the ses-
sions. Each group discussion was reorganized under the
identified themes. The prioritization instrument was
presented during the first meeting. Topic selection was
performed during the second meeting.
Step 3. Correspondence between main themes of the
survey of participants and key features of meetings
Results from content analysis of the survey of partici-
pants and content analysis of key features of meetings
were brought together and corresponding patterns were
looked for. Triangulation was used to increase the valid-
ity and reliability of the study in order to identify what
remains constant, or is common to all the different per-
spectives [21,22]. To establish communication functions
we made an internal analysis of texts and identified the
use of terms, and content. The texts were read with
care and re-read to identify key codes. Finally, we ana-
lyzed the properties of categories and explored connec-
tions between them. Interpretations were discussed
between authors, and after analyses, concordance was
reached. Resulting analysis was contrasted with those
obtained from the quantitative study [23].
The guideline development project was approved by
the ethics board committee of the National University
of Colombia. Written informed consent was not sought
in the internet-based survey but informed consent of
participants was implied because access to the question-
naire was restricted to persons approached by e-mail
explaining the study.
Results
Assignation of weight to identified criteria
Overall, 34 topics were proposed, of which 10 were cho-
sen. Mean values for each domain are summarized in
Table 1; the range is from 56.35 to 80.79. Teams consid-
ered disease burden, needs of information, feasibility and
effectiveness as the most relevant domains, while health
promotion and adverse events were considered the least
important. We found no statistical differences in weight-
ing domains for each topic (K. wallis p > 0.05) [Figure 2].
In addition, no significant differences related with the
four weighting systems were found when comparing
selected and non-selected topics [Table 3].
Classification of evidence used for PDT
T h er e p o r to ft h eq u a l i t yo ft h ei n f o r m a t i o nu s e dt o
judge the 41 items for each of the 34 prioritization
topics by every thematic team was mainly based on pro-
fessional experience (32%); 15% and 30% of the answers
were based on good and moderate quality information,
respectively, according to the respondents. The main
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effectiveness and disease burden, which had higher qual-
ity scores and weightings. Other relevant domains, such
as user preferences, social effects, adverse events and
economic impact were less used and had lower quality
report scores. The overall quality scores by topic are
summarized in Table 3. Finally, we found no statistical
differences in quality scores by topic among selected or
non-selected topics (K. wallis p > 0.05).
Factor Analysis
A factor analysis (explaining variance 92%) identified
three underlying components or factors: the first one
comprised clinical practice variation, adverse events,
information needs, effectiveness and disease burden; the
second factor included the social effects and user prefer-
ences; and the third factor comprised the economic
impact and health promotion. The main domains used
to support judgment having higher quality scores and
Figure 2 Participants’ score of relevance for each domain in the 34 evaluated topics and according to whether or not they were
selected.
Table 3 Comparison of selected topic relevance according to different weighting type procedures.
Topic relevance Non-weighted
procedure
Equal weights
procedure
Different weights
procedure
Weighted based on the external
survey
High relevance 2, 3 2, 3 2, 3 2, 3, 8
Intermediate
relevance
4, 5, 6, 7, 8 4, 5, 6, 7, 8, 9 4, 5, 6, 7, 8 4, 5, 6, 7
Low relevance 1, 9, 10 1, 10 1, 9, 10 1, 9, 10
1. Cardiology; 2. Gynecology; 3. Anesthesia; 4. Surgery; 5. Pediatrics; 6. Radiology A; 7. Nursing; 8. Radiology B; 9. Endocrinology; 10. Neurology.
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important domains, such as user preferences, social
effects and economic impact, had lower importance.
Qualitative analysis of PDT
All of the participants responded to the survey. Main
issues identified during PDT were the delays in estab-
lishing the teams, different working dynamics inside the
groups, the lack of familiarity with the use of virtual
tools, the short time available for literature searches,
and the lack of access to a number of full text articles.
Other factors, such as the management of hierarchies,
individual preferences and the power relations within
the groups, emerged in the participants’ comments and
were recognized as underlying factors that influenced
the decision making of groups.
Several factors were identified as facilitators for the
prioritization process: the development of a formal
instrument and instructive, the continued support of the
methodological teams, and the experience of the experts
on the proposed topics.
Participants suggested that future PDT processes
increase the teams’ awareness of the importance of
reducing the influence of internal factors such as indivi-
dual preferences and management of power relations in
decision making within each thematic group.
Discussion
Major findings
The priority setting process is usually complex, having
both quantitative and qualitative components [3-5]. To
the best of our knowledge, this is the first study that
formally incorporates the report of the quality of the
information for every domaini nt h ep r i o r i t i z a t i o no f
topics for CPGs. By developing a multi-criteria analysis
approach we used explicit items and transparent pro-
cesses to select topics for CPGs.
Our findings allowed us to identify that burden of dis-
ease, feasibility, and information needs were the most
relevant domains for the participants’ guideline topic
selection in our local settings. Adverse events and health
promotion had the lowest scores, probably suggesting
the low awareness that the experts have concerning
these domains. These findings should encourage CPG
developers to increase the awareness of the domains
that increase patient safety. Our study makes it clear
that although most proposals were considered because
of their priority importance, other topics were chosen
according to individual preference of the thematic team,
rather than as a result of a detailed search and evalua-
tion of the existing evidence for each topic. This poses a
challenge to methodologist researchers on how to man-
age political weights versus scientific weights in making
the final decision on prioritized CPG topics.
The use of a formal procedure generates data which
can be used with assertiveness and with results that pro-
vide an initial ranking list that helps to shape the deci-
sion-making process. Although we believed that the
relevance of weighting could be crucial in determining
the possible scores and helps to distinguish among the
most important topics in the prioritization process, our
study found no difference between the four tested
models.
The inclusion of the point of view of administrative
and methodology teams in the decision-making process
added a new component that increases the validity of
the chosen topics. Our results are similar to the findings
from Oortwijn et al. [5] who found that different ratings
of research proposals can have different policy relevance,
and that it was also necessary to include the point of
view of the organization for which the CPG is devel-
oped. However, the narrow range of scoring found for
each domain was probably due to the lack of knowledge
in some particular domains or to the low discriminatory
power in those domains.
One-third of the items were scored according to pro-
fessional experience and only 13% were supported with
good quality literature as reported by the participants.
Participants frequently reported good quality of the
information for effectiveness and feasibility domains.
Although the lack of time to generate information for
all the domains may have influenced findings, it could
also be due to the lack of skills in performing advanced
search strategies, the lack of evidence in some particular
topics and domains, as well as the lack of awareness in
a number of domains, as previously mentioned. Even if
the thematic teams had the possibility of asking a meth-
odologist to look for evidence, most of them did not
seek assistance. This is evidence of the lack of quantity
and quality that the information can have; routine deci-
sions are usually taken by clinical appraisers, and there
is a necessity to deepen the formation in evidence-based
medicine to support clinical decisions.
The prioritization method can be considered a feasible
and transparent approach toward setting priorities in
our context; however, the process is new and there is
still room for improvement. In the future, we will con-
sider developing strategies to ensure representativeness
of the experts, to evaluate the methodology by compar-
ing it to the results of other methods and to evaluate
the reports used to support the decisions and to socia-
lize our findings with a wider audience.
Limitations of our study approach
This study has several limitations; the methodology was
quite complex and included a number of quantitative
and qualitative approaches that reflects the difficulties of
the usual process of prioritization. Although, we
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criteria for PDT, there were inherent difficulties and
limitations. The sample selection of the external survey
was based on convenience sampling, which has limita-
tions for ensuring external validity. The composition
and structure of the groups may have an impact in the
individual and group decision making. Groups vary
according to their size, leadership styles, training, exter-
nal support, roles and rules among others. The way our
group was established may have some difference with
other guideline developers, limiting the external validity
of our study. Although we defined the scale for rating
the quality of the studies used to support the judgment
of the thematic teams, we did not use a formal tool and
we did not check for the accuracy of the interpretation
of the evidence provided by the participants.
Several studies have identified certain criteria, such as
disease burden, as the most important factors in the
decision-making process [14-17]. Although the findings
might have been biased by the choice of the thematic
team, we included different points of views to control
and socialize their topic selections, including an admin-
istrative team and a methodological consultant team. In
addition, this approach contributed toward identifying
the points of agreement and the points of controversy;
the discussion was therefore focused on the relevant
issues of the topic selection. Although the final decision
of the selection of topics had to be taken by the the-
matic teams, our approach led us to a short list of topics
in an open and verifiable process.
Conclusions
The results of this study draw attention to important
issues for policy-makers. Firstly, the selection of the
conditions in the decision-making process includes sev-
eral criteria at different levels. Secondly, not all criteria
are equally important for clinicians. The main advan-
tages of the proposed methodology are that it uses a
systematic approach to identify, score and weight guide-
line topics, limiting or exposing the influence of perso-
nal biases. In addition, the prioritization process
included the contributions of each stakeholder, in an
effort to prevent the possibility of a few stakeholders
taking over the process by producing biased topics for
CPG. It also clarified the process with the use of quanti-
tative measures and qualitative techniques, evaluating
different aspects of one specific topic which helped to
identify the strengths or weakness of the proposed alter-
native. We acknowledge there is a need for more epide-
miological research in our context, in order to provide
more accurate information to the guideline developers
so they can weigh up the criteria in a more precise way
for the selected topics.
Appendix 1. Search strategy for PUBMED
(“Guideline ” [Publication Type] OR “Guidelines as
Topic” [Mesh] OR “Practice Guideline ” [Publication
Type] OR clinical practice guideline* [tw] OR public
health guideline* [tw]) AND (Health Priorities [mh] OR
Health Priorit* [tw] OR priorit* setting [tw] OR (priorit*
method* [tw]) OR (priorit* technique* [tw]) OR (priorit*
strateg* [tw])).
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